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Abstract
Cyclotides are ultrastable plant proteins characterized by the presence of a cyclic amide backbone and three
disulfide bonds that form a cystine knot. Because of their extreme stability, there has been significant interest in
developing these molecules as a drug design scaffold. For this potential to be realized, efficient methods for the
synthesis and oxidative folding of cyclotides need to be developed, yet we currently have only a basic under-
standing of the folding mechanism and the factors influencing this process. In this study, we determine the major
factors influencing oxidative folding of the different subfamilies of cyclotides. The folding of all the cyclotides
examined was heavily influenced by the concentration of redox reagents, with the folding rate and final yield of
the native isomer greatly enhanced by high concentrations of oxidized glutathione. Addition of hydrophobic
solvents to the buffer also enhanced the folding rates and appeared to alter the folding pathway. Significant
deamidation and isoaspartate formation were seen when oxidation conditions were conducive to slow folding.
The identification of factors that influence the folding and degradation pathways of cyclotides will facilitate the
development of folding screens and optimized conditions for producing cyclotides and grafted analogs as stable
peptide-based therapeutics. Antioxid. Redox Signal. 14, 77–86.
Introduction
The cyclotides (6) are a remarkable family of plantproteins that are characterized by a head-to-tail peptide
backbone and six conserved cysteine residues that are paired
to form a knotted network of three disulfide bonds. The
combination of the circular peptide backbone and the tightly
knotted disulfide bonds defines the cyclic cystine knot (CCK)
motif. It is this feature that makes the cyclotides exceptionally
stable: they are resistant to thermal unfolding, chemical de-
naturants, and proteolytic degradation and their use in native
medicine as a uterotonic tea suggests that they are very stable
in biological systems (19). This inherent stability makes the
cyclotides an attractive scaffold for the design of peptide-
based therapeutics (8).
Over 140 cyclotides containing between 28 and 37 amino
acids have been reported to date (7, 45); example structures
and sequences are shown in Figure 1. The backbone segments
between the conserved cysteine residues, referred to as loops,
have varying levels of sequence diversity as illustrated in
Figure 1B. Loops 1 and 4 are highly conserved across all the
cyclotides and together with two disulfide bonds they make a
ring that is penetrated by the third disulfide to form the cys-
tine knot. Loop 6 has recently been identified as the point of
cyclization in the biosynthesis of the cyclotides and has a
highly conserved asparagine=aspartic acid residue that has
been recently shown to be critical in the processing of the
cyclotide precursor protein by an asparagine endopeptidase
(15, 35). The remaining loops (2, 3, and 5) are more variable in
size and composition, but several residues are still highly
conserved. Based on the presence or absence of a cis-Pro res-
idue in loop 5 the cyclotides have been divided broadly into
two subfamilies, namely the Mo¨bius and bracelet, respec-
tively.
The cyclotides exhibit a diverse range of biological activi-
ties. These include uterotonic (18), anti-HIV (22, 25, 45), he-
molytic (13, 36, 42), antimicrobial (42), antifouling (17),
antitumor (30, 40), and cardiotoxic activities (18), as well as
inhibition of trypsin (23) and neurotensin binding (48). In ad-
dition, they exhibit insecticidal, nematocidal, and molluscidal
properties and it is believed that the natural role of cyclotides in
plants is as a defense against predation (1, 26, 27, 33). Many of
1Division of Pharmacognosy, Department of Medicinal Chemistry, Biomedical Centre, Uppsala University, Uppsala, Sweden.
2Department of Pharmaceutical Chemistry, School of Pharmacy, Addis Ababa University, Addis Ababa, Ethiopia.
3Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia.
*These two authors contributed equally to this work.
ANTIOXIDANTS & REDOX SIGNALING
Volume 14, Number 1, 2011
ª Mary Ann Liebert, Inc.
DOI: 10.1089=ars.2010.3112
77
these biological activities are believed to be a result of cyclotides
interacting with biological membranes (28, 39, 46).
A number of three-dimensional structures of cyclotides
have been determined using nuclear magnetic resonance, in-
cluding kalata B1 and B2 (27, 34), cycloviolacin O1 (34), cir-
culins A and B (12), palicourein (2), tricyclon A (31), and
cycloviolacin O2 (16), and the X-ray structure of varv F was
recently reported (47). The conserved structural elements of
the cyclotides include a b-hairpin that is part of a triple-
stranded b-sheet formed by loops 4, 5, and 6. The third strand
(i.e., the one additional to the two strands of the b-hairpin) is
distorted from ideal geometry and contains a b-bulge. In ad-
dition, the bracelet cyclotides have a short section of helical
structure in loop 3.
A predominant feature of the cyclotides is the relatively
large number of hydrophobic residues that are exposed on
localized regions of the protein surface. In the Mo¨bius cyclo-
tides, such as kalata B1, the large hydrophobic patch is formed
predominantly by the residues of loops 5 and 6. In contrast,
the hydrophobic patch present in the bracelet cyclotides is
comprised of residues from loops 2 and 3. The hydrophobic
patch of the cyclotides is thought to have a major influence on
the folding of these peptides. Consistent with this proposal, it
has been shown that the addition of hydrophobic solvent and
detergents to the folding buffer in vitro significantly improves
the yield of correctly folded cyclotides (13, 29).
The relatively small size of the cyclotides (*30 amino ac-
ids) makes them amenable to chemical synthesis using solid-
phase methodologies. This facilitates the production of some
cyclotides that could otherwise only be isolated from natural
sources in small quantities, thus allowing their characteriza-
tion. In addition, chemical synthesis can be used to probe the
structure=activity relationships of the cyclotides and also
opens the possibility of using them as a molecular scaffold for
drug design. The general methodology for synthesizing cy-
clotides (4, 13, 29, 44) utilizes a solid-phase approach to as-
semble the peptide chain followed by backbone cyclization via
an intramolecular native chemical ligation reaction (14, 42).
The ligation reaction occurs in conjunction with the oxidative
folding of the peptide to form the cystine knot. The folding
conditions utilized during this step are critical in forming the
correct disulfide connectivity and hence the CCK motif.
There have been several studies investigating the oxidative
folding pathways of cyclotides in vitro and the influence of the
cyclic backbone on these processes. Folding studies on the
prototypical Mo¨bius cyclotide, kalata B1, have found that it
can be successfully folded in aqueous buffer containing a
hydrophobic cosolvent (isopropanol, iPrOH) and disulfide
shuffling reagent (reduced glutathione [GSH]) (13). The
folding pathway is dominated by a two-disulfide species that
possesses the native CysII-CysV and CysIII-CysVI bonds (9,
10). Interestingly, this species is not the direct precursor of the
native three-disulfide native peptide and the glutathione in
the buffer is required to reshuffle this two-disulfide species to
ultimately form the native peptide. To this date, the direct
two-disulfide precursor to kalata B1 is not known. The in vitro
folding of bracelet cyclotides has been only recently achieved,
as previously the conditions typically used for Mo¨bius cy-
clotides resulted in aggregated and insoluble peptide (29). A
comprehensive study of the effect of temperature, salt con-
centration, cosolvents, detergents, and shuffling reagents on
the folding of the bracelet cyclotide cycloviolacin O2 resulted
in a buffer system that results in the native peptide fold as the
major product. Interestingly, the folding of bracelet cyclotides
appears to be dominated by nonnative three-disulfide species,
with the formation of the CysI-CysII, CysIII-CysIV, and
CysV-CysVI isomer as a major energetic trap (29).
In the present study, we describe a comprehensive study of
the in vitro folding pathways of the two major subfamilies of
cyclotides, Mo¨bius and bracelet, and describe the similarities
and differences between the pathways in a range of buffer
conditions, highlighting the major intermediates accumulat-
ing for both families under the experimental conditions being
employed. An understanding of the mechanisms of cyclotide
folding and the effects of buffers on the formation of the native
isomer is of great importance in the development and ex-
ploitation of cyclotides and the CCK motif in drug design.
Materials and Methods
Isolation and reduction of cyclotides
The native Mo¨bius cyclotides, kalata B1 and B2, and the
hybrid cyclotide (i.e., part Mo¨bius, part bracelet), kalata B8,
were isolated from Oldenlandia affinis, whereas the bracelet
cyclotide cycloviolacin O2 was isolated from Viola odorata as
described previously (24, 32). In short, plant materials were
extracted using dichloromethane=methanol (1=1, v=v) or
ethanol=water (1=1, v=v). The extracts were subjected to
FIG. 1. Structures and sequences of cyclotides used in the
present study. (A) Three-dimensional structures of proto-
types for all three subfamilies: the Mo¨bius kalata B1 to the
left, the hybrid kalata B8 in the middle, and the bracelet
cyclotide cycloviolacin O2 to the right (protein data bank
codes 1nb1, 2b38, and 2knm, respectively). Note the cyclic
backbones, and the disulfide bonds forming the cystine knot
(cysteines are shown in yellow ball and stick format). The
arrangement of cystines is shown with Roman numerals:
CysI is connected to CysIV, CysII to CysV, and CysIII to
CysVI. These features are conserved in all subfamilies. (B)
Sequences of the four cyclotides used in the present study.
The alignment highlights some of the differences between
the subfamilies including the larger size of loop 3 in the
bracelet family that forms a helix; and loop 5 that contains
the cis-Pro bond that defines the Mo¨bius subfamily, or the
cluster of positively charged amino acids found in bracelets
in particular. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of
this article at www.liebertonline.com=ars).
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liquid–liquid extraction and concentrated in vacuo before solid-
phase extraction on C18 support. Pure cyclotides (>95%) were
then isolated using reverse-phase high-performance liquid
chromatography (HPLC).
After freeze drying, peptides were dissolved (1mg=ml) and
disulfide bonds were reduced using 1,4-dithiothreitol (3mg),
guanidine (6 M), and Tris-HCl (0.25 M, pH 8.5) containing
ethylenediaminetetraacetic acid (EDTA; 1mM) at 378C for 2 h.
Then, 2ml of this solution was injected and purified by re-
verse-phase HPLC at a flow rate of 1ml=min, using a mixture
of 5% B (60% AcN in 0.1% trifluoroacetic acid [TFA]) in A
(10% AcN in 0.1% TFA) for 8.5min to equilibrate the column,
followed by a linear gradient of 5%–70% B in A for 44.5min
and a cleaning phase of 100% B for 4.5min. Fractions were
collected and analyzed using electrospray mass spectrometry
(MS), and fractions containing reduced peptide were pooled
and freeze-dried. Peptides were then redissolved in eluent A
to a concentration of 0.3mM from which 100ml of solution
was aliqouted into Eppendorf tubes, freeze-dried, and used
for further experiments.
Oxidative folding
To analyze the kinetics of folding under different experi-
mental conditions, reduced peptides were dissolved in the
appropriate solvent (iPrOH or water) followed by the im-
mediate addition of reagents required for each experiment to
make a peptide concentration of 0.3mM in water or 0.25mM
in 50% (v=v) aqueous (aq.) iPrOH or 20% (v=v) aq. dimethyl
sulfoxide (DMSO) at 218C.
The effects of reducing agents on folding kinetics were
analyzed in 0.1 M NH4HCO3 (pH 8.5), in 0.1 M NH4HCO3
(pH 8.5) containing 50% (v=v) iPrOH and the following con-
centrations of GSH=oxidized glutathione (GSSG), 2=0, 2=0.4,
2=1, and 2=2mM, in 20% (v=v) DMSO in water, and in 0.1 M
Tris-HCl (pH 8.5) containing 1mM EDTA, 6% Brij 35, 35%
DMSO, 2mM cystamine, and 2mM GSH.
After addition of folding reagents, samples were flushed
with N2, sealed, and incubated at 218C. For each experiment,
an aliquot of 10 ml of solution was removed at the time inter-
vals 2min, 30min, 1 h, 2 h, 4 h, 6 h, 10 h, 24 h, and 72 h from the
reaction mixture and quenched by adding to 90ml of N-
ethylmaleimide (NEM) (60mM in 0.2 M citrate buffer, pH 3).
Samples from folding experiments were analyzed with li-
quid chromatography (LC)-MS, using a Shimadzu LC10
HPLC system connected to a Thermo-Finnigan LCQ electro-
spray ion trapMS. The capillary temperature was set at 2208C
and the spray voltage at 4.5 kV. Separation was done using a
Water Symmetry C18 column (1502.1mm inner diameter
(i.d.), 5mm, 300 A˚) at a flow rate of 0.3ml=min and by using
the following standard gradient: 5% B in A (using formic acid,
FA, instead of TFA) for 2min to equilibrate the column, fol-
lowed by 5%–30% B in A for 2min, a linear gradient of
30%–65% B in A for 21min, 65%–100% B in A in 2min, and a
washing step of 100% B in A for 2min. A volume of 20 ml of
the trapped sample was injected.
Different peak areas obtained after LC-MS analysis were
used as a layout for integration of the peaks. The areas under
the curve in 4 mass unit wide windows were calculated,
centered at the doubly charged ions [(Mþ 2H)2þ] of each
peptide species (peptide with native disulfides [N], peptide
containing three disulfide bonds [3SS], peptide containing
two disulfide bonds [2SS], peptide containing one disulfide
bond [1SS], and reduced peptide [R], respectively) of kalata B1
(1447.6, 1573.9, 1699.3, 1826.2), kalata B2 (1479.2, 1605.4,
1731.0, 1862.1), and cycloviolacin O2 (1572.1, 1698.0, 1821.4,
1846.4), and the triply charged [(Mþ 3H)3þ] ions of kalata B8
(1097.2, 1181.3, 1264.7, 1348.9) were integrated. Then the
percentage represented by each subset was calculated from
the areas under the curve values for each experimental con-
dition and at each sampling time point (2min, 30min, 1 h, 2 h,
4 h, 6 h, 10 h, 24 h, and 72 h). Graphs were constructed using
the quantities of each species (expressed in percentage).
All graphs are shown in Supplemental Figures 1–5 (see www
.liebertonline.com=ars).
Results
The main objective of the present study was to gain deeper
insights into the external factors that influence oxidative
folding of cyclotides. To this end, we systematically mapped
the oxidative folding of selected members of each cyclotide
subfamily in a standardized set of folding conditions and
compared the final yield of native peptide, folding kinetics,
and the accumulation of nonnative isoforms.
Four cyclotides were chosen to represent the two main
subfamilies: besides kalata B1, which is the most well-
studied cyclotide and the prototype for the Mo¨bius sub-
family, kalata B2 was included for comparison within the
Mo¨bius subfamily, together with prototypes for the bracelet
and the growing Mo¨bius=bracelet hybrid subfamilies in the
form of cycloviolacin O2 and kalata B8, respectively. These
peptides were all isolated from cyclotide-containing plants,
the three disulfide bonds were then reduced, and the fully
reduced species were isolated. Aliquots of the reduced
material were then subjected to oxidative refolding at the
different folding conditions. The reaction mixture was
sampled during the folding process, and the progress was
monitored using LC-MS.
To monitor the progress of oxidative folding, which is the
formation of disulfide bonds to the native connectivity and
structure, is an analytical challenge, even with the combina-
tion of LC andMS. Ongoing folding processes and reshuffling
of disulfide bonds even after sampling, highly similar overall
folds and structures, and the need to distinguish between ions
of doubly and triply charged disulfide species with relatively
small mass differences in peptides of molecular weights of
*3000 (the corresponding mass shifts for one, two, or three
disulfides bonds are 2, 4, or 6 mass units) with overlapping
isotopic envelopes are some of the main difficulties that need
to be addressed. To circumvent these problems in the present
study, we used a strategy of capping free thiols at low pH
using NEM to quench disulfide reshuffling and to introduce a
mass difference between disulfide species that are fully re-
duced or containing one, two, or three disulfide bonds as
multiples of the molecular weight of NEM (125 g=mol). Then,
the fully reduced peptide (R) accumulates 750 mass units
(6NEM), one disulfide species (1SS) 500mass units (4NEM),
and two disulfide species (2SS) 250 mass units (2NEM),
whereas no additional mass is conferred to the three-disulfide
species (3SS), of which the native peptide (N) is one. These
folding species include in total 76 individual species (R,
151SS, 452SS, 153SS including N), which all are treated
as subsets with the exception of the native peptide. N was
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distinguished from the 3SS subset by means of its retention
time and comparisons with native peptides isolated from
plants. The ability to distinguish between native and non-
native 3SS disulfides species is important, as one of the spe-
cific aims of the present study was to evaluate the different
folding systems in terms of final yield.
The standard buffer systems for cyclotide folding are based
on the early work by Daly et al. (13), in which 0.1 M ammo-
nium bicarbonate and 1mM GSH in water was successfully
used for folding of the prototypic cyclotide kalata B1. In that
study it was also found that the folding efficiency of that
Mo¨bius cyclotide was improved in the presence of iPrOH
(50%), which was hypothesized to stabilize the hydrophobic
surface of the peptide. Therefore, it was logical to include
these two buffer systems in the present study as bases for a
systematic survey.
Using these two folding systems (0.1 M NH4HCO3, with
and without iPrOH) and kalata B1 as model peptide, we first
focused on the influence of redox agents, particularly on
folding kinetics and final yield. The concentration of GSHwas
set at 2mM, and four different concentrations of GSSG were
used: 0, 0.4, 1, and 2mM. All experiments were done under N2
to avoid air oxidation. Under all conditions, 1SS and 2SS in-
termediates were observed as the folding reaction proceeded,
which can be seen in the complete set of folding curves found
as Supplemental Figure 1. Not surprisingly, the speed of the
reaction increased at higher concentrations of GSSG. For ex-
ample, whereas 1SS and 2SS species dominate the folding
mixture after 4–6 h at GSH=GSSG concentrations of 2=0mM
and are still found after 24 h of incubation, all peptides have
been converted into 3SS species in GSH=GSSG 2=2mM after
only 1 h, as shown in Figure 2A and B. However, a significant
proportion of these 3SS species were nonnative peptides, as
judged from their LC-MS retention times, in folding buffers
that did not contain iPrOH. In particular, nonnative 3SS
species were the dominant species early in the reaction at 2=1
and 2=2mM GSH=GSSG. However, in the presence of iPrOH
(Fig. 2C and D) the level of such nonnative 3SS species de-
creased. As exemplified in Figure 2D, the route to N seems to
bypass the accumulation of nonnative 3SS species in the
presence of iPrOH, because of either a rapid conversion of
these 3SS species to N, or a direct route from 2SS to N. This
observation is consistent with the hypothesis that the hydro-
phobic fold of N is stabilized in the presence of organic solvent
(13). In fact, iPrOH also stabilizes 2SS species that have native-
like overall folds, as exemplified by the 2SS kinetic trap
identified in (10); in the present study, the stable 2SS isomer
contributes to the prolonged lifetime of 2SS species as shown
in Figure 2C. Using only GSSG, the folding rate was increased
even further (see graphs in Supplemental Fig. 1).
Importantly, the ability of iPrOH to stabilize N also helps in
preventing deamidation of native kalata B1. Kalata B1 con-
tains an Asn-Gly sequence that is surface=solvent exposed
(consistent with it being the site of backbone cyclization),
which might be prone to deamidation by formation of as-
partimide followed by ring opening to Asp and iso-Asp, as
FIG. 2. Folding of kalata B1. (A) Reduced kalata B1 (R) in 0.1 M NH4HCO3 and 2mM reduced glutathione (GSH) folds
slowly via partly reduced species (peptide containing one disulfide bond [1SS] and peptide containing two disulfide bonds
[2SS]). (B) Adding 2mM oxidized glutathione (GSSG) makes folding much faster and via nonnative species with all cysteines
oxidized (peptide containing three disulfide bonds [3SS]). (C) Adding the organic solvents isopropanol (iPrOH) also increases
folding speed but not via 3SS derivates. (D) Folding in the presence of both GSSG and iPrOH oxidizes kalata B1 into native
fold within a few hours. (Graphs of all folding experiments are provided as Supplemental Fig 1.)
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depicted in Figure 3A. A detailed mapping using shallow
gradient LC and offline MS, together with MS=MS analyses,
shows that the latter two derivatives are significant side
products in reactions done in ammonium bicarbonate buffer
lacking iPrOH after extended incubation times (>72 h). The
two peaks eluting immediately after the native peptide in
Figure 3B had a mass increase of 1 mass unit compared with
N. The position of the mass increase was localized to the Asn
residue by MS=MS (data not shown). This observation is
consistent with the conversion of Asn to Asp=iso-Asp.
Strikingly, these derivatives constitute the main products at
some conditions when folding rates are slow (e.g., at
GSH=GSSG 2=0mM) and in the absence of iPrOH. Besides
demonstrating an obvious stabilizing effect of iPrOH, these
data suggest that deamidation occurs at all stages when the
peptide is flexible in solution, including 3SS species that are
in equilibrium with N.
Having established the influence of redox agents for the
folding of kalata B1, 2=2mM GSH=GSSG were chosen as
standard concentrations for the folding experiments with the
Mo¨bius kalata B2, the bracelet cycloviolacin O2, and the hy-
brid kalata B8. In addition, the oxidative folding system re-
cently developed specifically for the bracelet cyclotide
cycloviolacin O2 (29) and a DMSO-based redox system were
included (41). Specifically these buffers comprise 0.1 M Tris-
HCl (pH 8.5) containing 1mM EDTA, 6% Brij 35, 35% DMSO,
and 2mM cystamine, 2mM GSH as redox agent, 20% DMSO,
and 0.1 M ammonium bicarbonate.
The full set of graphs of those experiments can be found in
Supplemental Figures 2–5; Figure 4, however, summarizes
the folding efficiency of the different buffers, in terms of yield
of N after selected time points of 30min, 2 h, 6 h, and 24 h. The
main difference between the three subfamilies is that the
bracelet type is less prone to fold into the native structure,
confirming earlier observations (20, 29). The yields of the
Mo¨bius cyclotides, kalata B1 and B2, and the hybrid kalata B8
all reach *80% (or more) at some stage in some buffers,
whereas the yield of the bracelet prototype reached a maxi-
mum of *23% in the optimized buffer developed especially
for that peptide. In other buffers used, the yield of native
cycloviolacin O2 is negligible.
A closer examination of the yields shows that the two
Mo¨bius cyclotides follow the same folding pattern in the
different buffers. The ammonium bicarbonate buffers with
and without iPrOH result in good yields over 24 h and so
does the buffer specifically designed for the bracelet cyclo-
violacin O2. However, the DMSO-containing ammonium
bicarbonate buffer only gives N in yields of 10% and 16% for
kalata B1 and B2, respectively, after 24 h. The levels of R,
1SS, or 2SS are negligible at any time point longer than 1 h
for these cyclotides, with the exception of the 20% DMSO
buffer, in which 2SS species are found at high levels up to
4 h. Noteworthy is also the equilibrium that is established
between N and other 3SS species, which means that the
yield of N does not increase at longer incubation times.
These facts are clearly demonstrated by the folding curves
found in Supplemental Figures 2–5, and exemplified by the
folding curves for kalata B2 and cycloviolacin O2 in Figure
5, in which the equilibrium is established at a very low level
of N. The folding of kalata B8 follows the same trends as the
Mo¨bius cyclotides, although the final yield is lower in most
buffers.
FIG. 3. Deamidation of kalata B1. Peptides, such as kalata
B1, containing Asn-Gly sequences are particularly sensitive
to deamidation, that is, the conversion of Asn to Asp and i-
Asp as outlined in A. This reaction occurs spontaneously in
solution at neutral pH. (B) The effects of that reaction after
prolonged exposure in ammonium bicarbonate (pH 7.8),
2mM GSH folding buffers with and without 50% iPrOH. The
trace at the bottom shows the folding progress after 30 s: the
reduced peptide (R, eluting at *18min) dominates in both
buffers. The middle trace shows the folding after 72 h in the
buffer containing iPrOH: N is the dominating product, but
the two deamidation products emerge immediately after
peptide with native disulfides (N) (i-Asp, iD; Asp, D). The
upper trace shows the products in the buffer without iPrOH
at the same time point; here the i-Asp derivative is the main
product. Note the cluster of peaks occurring around 20min
in that trace: these are all 3SS products. Most likely these 3SS
species are more susceptible to deamidation. The analyses
were done using a Grom-Sil ODS-4 HE (1252 [i.d.]mm,
3mm, 200 A˚) column eluted with the following gradient from
A (0.05% TFA in water [v=v]) to B (90% AcN in 0.045% TFA)
at a flow rate of 0.3ml=min: 0–5min, 10% B; 5–10min, 10%–
27% B; 10–40min, 27%–42% B; 40–45min, 42%–100% B; 45–
49min, 100% B; 49–50min, 100%–10% B.
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Discussion
Developing an understanding of the pathway to formation
of the topologically intriguing CCK motif, in vivo and in vitro,
has been a major aim since the discovery and characterization
of the first cyclotides. Aside from the fundamental interest in
such novel protein topologies, there are practical benefits in
understanding their folding pathways. For example, although
approximately two-thirds of cyclotides belong to the bracelet
subgroup, an understanding of the structure=function rela-
tionships of these peptides is relatively limited because of
poor yields during oxidative folding and hence a lack of
chemical mutagenesis studies. There is also significant interest
in using cyclotides as scaffolds for grafting of bioactive pep-
tide epitopes to produce stabilized peptide-based drug leads
(5, 21, 43). However, advances in this area have, to some ex-
tent, been hampered by the lack of knowledge and ap-
proaches for the efficient folding in vitro of these reengineered
cyclotides. The present study is the first attempt at a system-
atic evaluation of the oxidative folding, in terms of final yield
and kinetics, of four protypical cyclotides.
The first part of the evaluation involved fine tuning of the
redox system used, GSH and GSSG, which helps in the oxi-
dation process by thiol=disulfide interchange. In these ex-
periments, GSH concentration was kept constant, as the
concentration of GSSG was varied. Not surprisingly, the re-
sults showed that the folding rate increased by decreasing the
ratio of GSH=GSSG (i.e., by decreasing GSH or increasing
GSSG concentrations). This trendwas the same in ammonium
bicarbonate buffers with and without organic solvent. In-
corporation of iPrOH into the folding buffer had a significant
impact on the folding process for kalata B1. In ammo-
nium bicarbonate buffer alone, folding was dominated by
nonnative-like species, either 1SS or 2SS when GSSG was not
present or 3SS species when GSSG was included. When
iPrOH was added, more native-like folds were favored in the
form of the stable 2SS intermediate identified previously (10)
in the absence of GSSG or through the rapid formation of the
native kalata B1 in the presence of GSSG. (The full set of
folding curves is found as Supplemental Fig 1.)
We also observed that the folding rate, and thus indirectly
the concentration ratio of redox agents, has a dramatic effect
not only on the quantity of native peptide obtained but also on
the degree of side reactions forming unwanted byproducts.
Kalata B1, which was used as a model peptide in these initial
experiments, contains an Asn-Gly sequence that was shown
to be susceptible to conversion to Asp or iso-Asp via deami-
dation of Asn. This reaction is favored by a low degree of
steric hindrance by the amino acid in the Asnþ 1 position and
by conformational effects such as flexibility and solvent ex-
posure. Both these conditions are fulfilled by kalata B1 during
the folding process: the residue following Asn is Gly, and
although cyclotides are stable and rigid molecules during the
folding process, they do exhibit a significant degree of flexi-
bility in the absence of disulfide bonds. Indeed, even three-
disulfide-bond species have been shown to be flexible in
solution in an earlier study (29).
FIG. 5. Equilibriums are formed between N and 3SS species. Folding of cycloviolacin O2 gives low yield even in the
folding buffer designed for that purpose: (A) Lower oxidation state products quickly disappear, followed by the establish-
ment of an equilibrium between N and 3SS species. Kalata B2 shows a similar behavior in the 20% DMSO ammonium
bicarbonate buffer (B); however, both 1SS and 3SS species are more long lived than in the case of A.
FIG. 4. Kinetics and yield of native cyclotide cyclotides in
various buffers. Fully reduced kalata B1, B2, B8, and cy-
cloviolacin O2 (KB1, KB2, KB8, and CyO2, respectively) were
folded in four different buffers. Yields of native folds are
shown as columns at four time points (30min, 2 h, 6 h, and
24 h). The Mo¨bius cyclotides KB1 and KB2 were possible to
fold in all buffers but with low yields in the dimethyl sulf-
oxide (DMSO)-based system. The hybrid KB8 showed a
similar pattern but with a lower final yield overall. The
bracelet cyclotide CyO2 folded into N only in the buffer es-
pecially optimized for that cyclotide (at a yield of 23%).
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We were able to favor the formation of the deamidated
derivatives by using conditions that induce slow folding (i.e.,
the absence of GSSG and by using prolonged incubation
times). At all sampled time points and at all tested concen-
trations of redox agents, however, the degree of deamidation
significantly decreased if organic solvent (i.e., iPrOH) was
included in the folding buffer. This result is probably due to a
stabilizing effect of the hydrophobic surface of the correctly
folded cyclotide. This hypothesis is supported by the fact that
the relative amount of kalata B1-folding products that have
nonnative 3SS conformations is significantly lower in the
presence of iPrOH, as shown by the HPLC analyses in Figure
3. Hypothetically, deamidation is a continuous reaction when
the peptide occurs as these species, as they are more flexible
than the native fold.
It is clear from these studies that choosing and keeping
redox conditions under control is a key to a high-quality
product. Our results also show the possible effects of storing
cyclotides in solutions, which might favor reshuffling of dis-
ulfides and thereby promote flexibility and subsequent dea-
midation. The problem likely extends to other cyclotides,
particularly when considering that the Asn-Gly sequence is
present in most cyclotides, as it is the putative site of cycli-
zation [other cyclotides contain Asp-Gly, which may be con-
verted into iso-Asp but by a much lower degree (11)]. Of the
other cyclotides studied in the present work, only cyclovio-
lacin O2 contains Asn-Gly; we have not yet been able to detect
any deamidated derivative of that peptide, most likely be-
cause it only folds in the specifically designed buffer that
provides a highly stable environment for N.
We then turned to the folding evaluation of the four pro-
totypic cyclotides: kalata B1 and B2 from the Mo¨bius sub-
family, cycloviolacin O2 from the bracelets, and the hybrid
cyclotide kalata B8, which shares structural features fromboth
the Mo¨bius and bracelet subfamilies. Progress of the folding
was followed over time in four different folding systems, and
the ratios of R, 1SS, 2SS, 3SS, and N were calculated. All
folding systems have been previously proven for some cy-
clotides: the ammonium bicarbonate buffers with and with-
out iPrOH have been the standard buffers for most cyclotides
syntheses (13, 38), albeit in the present experiments we used
the optimized concentration of redox agents; the 20% DMSO
is similar to the conditions used by Tam and coworkers for
two-disulfide formation in a directed disulfide formation
strategy for cyclotide synthesis (42); and finally, the rather
complex buffer that was developed for the first direct folding
of a bracelet cyclotide (cycloviolacin O2) (29).
These folding experiments confirmed that the in vitro oxi-
dative folding of cyclotides can be very efficient in optimal
conditions. There are some interesting aspects to the folding
experiments, some unique to the individual examples used in
the present study, with respect to the speed and efficiency of
the disulfide bond formation. For the prototypical Mo¨bius
cyclotide, kalata B1, it was observed that the folding rate was
slightly higher in ammonium bicarbonate buffer alone com-
pared with when iPrOH was included in the system. For ka-
lata B2, the second Mo¨bius cyclotide studied, and the hybrid
kalata B8, the opposite trend was observed, with the addition
of iPrOH accelerating the folding. None of the tested cyclotides
exhibited significant folding to the native isomer in the DMSO
buffer. The bracelet cyclotide, cycloviolacin O2, only folded to
the native isomer in the cycloviolacin O2-folding buffer as
previously described (29). Interestingly, this oxidation buffer
also produced native peptide for the other three cyclotides.
Although theMo¨bius cyclotides essentially follow the same
folding pattern in terms of rate and yield of N, and also of the
production of the 1SS and 2SS families of disulfide species,
they differ significantly from the hybrid and bracelet cyclo-
tides at the tested folding conditions (c.f. Fig. 5). An exami-
nation of the structures of these cyclotides helps in explaining
these observations. Although the structures of the backbone
and the overall sizes of the molecules are similar (i.e., they all
share the CCK motif ), there are major differences when
focusing on the properties of surface-exposed amino acid
residues, as shown in Figure 6, particularly with respect to
the degree and position of hydrophobic and charged resi-
dues. Although primarily residues in loops 5 and 6 form a
hydrophobic patch in the two Mo¨bius cyclotides, kalata B1
FIG. 6. Surface representations of aligned kalata B1, B2,
B8, and cycloviolacin O2. In the Mo¨bius cyclotides, kalata B1
and B2, the residues of loops 5 and 6, form a large hydro-
phobic patch, whereas in the bracelet cycloviolacin O2 the
hydrophobic patch is comprised of residues from loops 2 and
3. The hybrid kalata B8 that consist of loops typical from
both subfamilies lacks a well-defined hydrophobic patch.
The hydrophobic patch of the cyclotides has a major influ-
ence on activity as well as the folding of the peptide. The
hydrophobic residues (Ala, Leu, Ile, Pro Trp, Phe, and Val)
are in green, cationic residues (Arg and Lys) in blue, anionic
residues (Asp and Glu) in red, and other residues in white.
(For interpretation of the references to color in this figure
legend, the reader is referred to the web version of this article
at www.liebertonline.com=ars).
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and B2, this region of the molecule is hydrophilic and charged
in the bracelet cycloviolacin O2. On the contrary, cycloviola-
cin O2 displays a large hydrophobic patch centered around
loop 2 and the a-helix in loop 3; the corresponding part of
Mo¨bius cyclotides is hydrophilic in nature. In comparison,
kalata B8 has a relatively hydrophilic surface, lacking large
hydrophobic surface patches. It has recently been shown
that the location of these hydrophobic patches determines
the mode of interaction with model membranes (37, 46).
Hypothetically, these results can also be extended to their
different folding behavior: the more amphipathic structure of
cycloviolacin O2 requires not only a hydrophobic cosolvent
but also a detergent for stabilization of the native form.
Although a good yield of N is the main purpose for most
folding experiments, the demonstrated possibility to push
equilibria to nonnative 3SS species, or to trap disulfide species
of lower oxidation states by using slow or low-yielding fold-
ing systems, is potentially a valuable step toward a detailed
understanding of the formation of the CCK motif. Currently,
only one intermediate has been identified on the folding
pathway of kalata B1, the most studied cyclotide. That 2SS
species, shown in Figure 7, acts as kinetic trap (10) and is a
major contributing factor to the high level of 2SS species in the
iPrOH-containing buffer as shown by the folding curves in
Figure 2. Using buffers that stabilize intermediates, for ex-
ample, 20% DMSO=ammonium bicarbonate, could facilitate
the isolation and identification of additional intermediates to
provide a detailed map of the route to N.
Comparing the subsets of folding products and kinetics
between the cyclotides in the present study reveals that the
different subfamilies seem to follow two different routes to N,
as outlined in Figure 7. The Mo¨bius and hybrid cyclotides
show 1SS=2SS species that are converted into N over a rela-
tively long time span, whereas partially reduced (i.e., 2SS)
bracelet cycloviolacin O2 quickly collapses into nonnative 3SS
species during oxidative folding. This is demonstrated in the
folding curves found as Supplemental Figures 2–5: for ex-
ample, the oxidation of cycloviolacin O2 2SS species in am-
monium bicarbonate are effectively trapped as nonnative 3SS
species, and only trace amounts of the lower oxidation forms
(1SS=2SS) could be detected in the buffer designed for
bracelets after 2min. This suggests that Mo¨bius=hybrids fol-
low a 2SS to N route, whereas bracelets follow a pathway in
which N is formed via concerted reshuffling of 3SS species.
Alternatively, they all follow the same pathway, but their
corresponding 3SS species are=is less stable; in that case a 3SS
species could be the elusive direct precursor of N in all cy-
clotides. In this context it is noteworthy that the nonnative 3SS
species depicted in Figure 7 has been recently identified as a
major intermediate during the folding of cycloviolacin O2 and
a synthetic Mo¨bius=bracelet mutant (20, 29).
To date, a magic recipe has yet to be formulated that can be
applied to the folding of all cyclotides. The need for such a
recipe remains important as their stability and sequence di-
versity makes cyclotides attractive options as scaffolds for
drug design. Their CCK motif has been shown to be essential
for their exceptional stability, and therefore, it is vital that
folding conditions are chosen for grafted analogs that generate
molecules with a native fold. Cyclotides show promise as
bearers of bioactive sequence epitopes, but even if there are
some successful examples of active cyclotide analogs (21, 43),
many of the trial-and-error peptidesmade in the course of these
studies do not fold into cyclotide-like molecules. The results in
the present study demonstrate that a plausible way to efficient
folding is the development of a focused set of screening con-
ditions, analogous to those used for screening crystallization
conditions for X-ray studies (3). For that purpose, the buffer
systems described here form a valuable starting point.
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Abbreviations Used
0SS¼ reduced peptide without disulfide bonds
1SS¼peptide containing one disulfide bond
2SS¼peptide containing two disulfide bonds
3SS¼peptide containing three disulfide bonds
CCK¼ cyclic cystine knot
DMSO¼dimethyl sulfoxide
EDTA¼ ethylenediaminetetraacetic acid
GSH¼ reduced glutathione
GSSG¼ oxidized glutathione
HPLC¼high-performance liquid chromatography
iPrOH¼ isopropanol
LC¼ liquid chromatography
MS¼mass spectrometry
N¼peptide with native disulfides
N3SS¼native peptide with three native disulfide bonds
NEM¼N-ethylmaleimide
NN3SS¼nonnative peptide fold containing three disulfide
bonds
R¼ reduced peptide
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